Massachusetts Financial Services
TVTX icon

Massachusetts Financial Services’s Travere Therapeutics TVTX Stock Holding History

Massachusetts Financial Services’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-81,037
Closed -$2.52M – 903
2021
Q4 		$2.52M Sell
81,037
-1,642
-2% -$46.2K ﹤0.01% 755
2021
Q3 		$2M Sell
82,679
-17,062
-17% -$313K ﹤0.01% 783
2021
Q2 		$1.46M Buy
99,741
+856
+0.9% +$16.9K ﹤0.01% 811
2021
Q1 		$2.47M Sell
98,885
-11,719
-11% -$324K ﹤0.01% 743
2020
Q4 		$3.02M Sell
110,604
-1,108
-1% -$25.9K ﹤0.01% 700
2020
Q3 		$2.06M Sell
111,712
-4,377
-4% -$85.1K ﹤0.01% 714
2020
Q2 		$2.37M Buy
116,089
+27,664
+31% +$440K ﹤0.01% 674
2020
Q1 		$1.29M Buy
88,425
+13,995
+19% +$211K ﹤0.01% 716
2019
Q4 		$1.06M Buy
74,430
+17,587
+31% +$225K ﹤0.01% 756
2019
Q3 		$658K Buy
+56,843
New +$939K ﹤0.01% 787

Other funds holding TVTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Massachusetts Financial Services's TVTX Position: Q1 2022 in Review

Massachusetts Financial Services sold out of Travere Therapeutics (TVTX) in Q1 2022, closing a stake of 81,037 shares — an estimated $2.52M sold.

Massachusetts Financial Services first reported a position in TVTX in Q3 2019 and held it in 10 quarters. The position peaked at $3.02M in Q4 2020. 169 funds tracked by Wall St. Rank hold TVTX as of Q1 2022.

  • Massachusetts Financial Services reported no remaining Travere Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Massachusetts Financial Services sold 81,037 Travere Therapeutics shares in Q1 2022, an estimated $2.52M.
  • Massachusetts Financial Services first reported a position in Travere Therapeutics in Q3 2019 and held it in 10 quarters.
  • Massachusetts Financial Services's Travere Therapeutics position peaked at $3.02M in Q4 2020.
  • 169 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2022.

Based on Massachusetts Financial Services's 13F filing for Q1 2022, filed 11 May 2022.